MSNBC Way Too Early With Kasie Hunt February 15, 2021 10:53:00
With proven overall survival results in 2 clinical trials. helping women live longer with hr+, her2- metastatic breast cancer. kisqali was also significantly more effective at delaying disease progression... ...versus a nonsteroidal aromatase inhibitor or fulvestrant alone. kisqali can cause lung problems or an abnormal heartbeat, which can lead to death. it can cause serious skin reactions, liver problems, and low white blood cell counts that may result in severe infections. tell your doctor ri...
Source: archive.org